4D Molecular Therapeutics... (FDMT)
undefined
undefined%
At close: undefined
6.50
0.15%
After-hours Dec 13, 2024, 04:15 PM EST

4D Molecular Therapeutics Inc. Forcast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for FDMT stock have an median target of 39, with a low estimate of 36 and a high estimate of 58. The median target predicts an increase of 500.92% from the current stock price of 6.49.

Analyst Consensus: Buy
Target Low Average Median High
Price $36 $41.86 $39 $58
Change 454.70% 544.99% 500.92% 793.68%

AI Analyst Report

Chardan Capital has reaffirmed a Buy rating for 4D... Unlock content with Pro Subscription

Updated Nov 14, 2024

Rating May 24Jun 24Jul 24Aug 24Sep 24Nov 24
Strong Buy 000010
Buy 123133
Hold 000010
Sell 000001
Strong Sell 000000
Total 1 2 3 1 5 4

Financial Forecast this Year

Revenue This Year
5.24M
from 20.72M
Increased by -74.7%
Revenue Next Year
7.29M
from 5.24M
Increased by 39.3%
EPS This Year
-2.71
from -2.58
Increased by -5%
EPS Next Year
-3.02
from -2.71
Increased by -11.4%